{"title":"NUAK1 Inhibition Alleviates Ischemia-Reperfusion Injury via SYNE1-YAP1.","authors":"Yangjinming Bai,Tingting Zhao,Qian Wang,Rui Zhang,Zhixing Wei,Yudong Fei,Xingxing Cai,Zhengyang Wu,Ji Yan,Yichao Zhang,Kaiyan Chen,Yuepeng Wang,Yi-Gang Li","doi":"10.1161/circresaha.126.328256","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nMechanosensitive nuclear signaling contributes to myocardial ischemia-reperfusion injury, but the substrates and mechanisms of NUAK1 (AMPK-related kinase 5) remain unclear. We investigated whether NUAK1 regulates SYNE1 (Nesprin-1)/linker of nucleoskeleton and cytoskeleton-dependent nuclear gating of YAP1 (Yes-associated protein 1) during hypoxia/reoxygenation and ischemia-reperfusion injury.\r\n\r\nMETHODS AND RESULTS\r\nQuantitative phosphoproteomics identified a conserved NUAK1-dependent phosphorylation site in striated muscle-enriched Nesprin1-α2/SYNE1 (S434; S8284 in nesprin-1 giant). Coimmunoprecipitation and in vitro kinase assays supported direct SYNE1 phosphorylation by NUAK1. In neonatal mouse ventricular myocytes, genetic or pharmacological inhibition of NUAK1 decreased apoptotic signaling, reduced SYNE1 stability, enhanced YAP1 nuclear localization, and altered nuclear YAP1 dynamics. SYNE1 phosphosite mutants and nuclear/cytoplasmic fractionation supported a NUAK1-SYNE1 axis that restrains YAP1 nuclear accumulation under stress. Atomic force microscopy linked this pathway to nuclear mechanical remodeling. In a mouse model of ischemia-reperfusion injury, NUAK1 inhibition reduced acute myocardial damage and improved remodeling indices.\r\n\r\nCONCLUSIONS\r\nNUAK1-dependent SYNE1 phosphorylation shapes nuclear mechanosignaling during ischemic stress. NUAK1 downregulation promotes cardiomyocyte YAP1 nuclear activity and attenuates injury responses.","PeriodicalId":10147,"journal":{"name":"Circulation research","volume":"13 1","pages":""},"PeriodicalIF":18.0000,"publicationDate":"2026-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/circresaha.126.328256","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND
Mechanosensitive nuclear signaling contributes to myocardial ischemia-reperfusion injury, but the substrates and mechanisms of NUAK1 (AMPK-related kinase 5) remain unclear. We investigated whether NUAK1 regulates SYNE1 (Nesprin-1)/linker of nucleoskeleton and cytoskeleton-dependent nuclear gating of YAP1 (Yes-associated protein 1) during hypoxia/reoxygenation and ischemia-reperfusion injury.
METHODS AND RESULTS
Quantitative phosphoproteomics identified a conserved NUAK1-dependent phosphorylation site in striated muscle-enriched Nesprin1-α2/SYNE1 (S434; S8284 in nesprin-1 giant). Coimmunoprecipitation and in vitro kinase assays supported direct SYNE1 phosphorylation by NUAK1. In neonatal mouse ventricular myocytes, genetic or pharmacological inhibition of NUAK1 decreased apoptotic signaling, reduced SYNE1 stability, enhanced YAP1 nuclear localization, and altered nuclear YAP1 dynamics. SYNE1 phosphosite mutants and nuclear/cytoplasmic fractionation supported a NUAK1-SYNE1 axis that restrains YAP1 nuclear accumulation under stress. Atomic force microscopy linked this pathway to nuclear mechanical remodeling. In a mouse model of ischemia-reperfusion injury, NUAK1 inhibition reduced acute myocardial damage and improved remodeling indices.
CONCLUSIONS
NUAK1-dependent SYNE1 phosphorylation shapes nuclear mechanosignaling during ischemic stress. NUAK1 downregulation promotes cardiomyocyte YAP1 nuclear activity and attenuates injury responses.
期刊介绍:
Circulation Research is a peer-reviewed journal that serves as a forum for the highest quality research in basic cardiovascular biology. The journal publishes studies that utilize state-of-the-art approaches to investigate mechanisms of human disease, as well as translational and clinical research that provide fundamental insights into the basis of disease and the mechanism of therapies.
Circulation Research has a broad audience that includes clinical and academic cardiologists, basic cardiovascular scientists, physiologists, cellular and molecular biologists, and cardiovascular pharmacologists. The journal aims to advance the understanding of cardiovascular biology and disease by disseminating cutting-edge research to these diverse communities.
In terms of indexing, Circulation Research is included in several prominent scientific databases, including BIOSIS, CAB Abstracts, Chemical Abstracts, Current Contents, EMBASE, and MEDLINE. This ensures that the journal's articles are easily discoverable and accessible to researchers in the field.
Overall, Circulation Research is a reputable publication that attracts high-quality research and provides a platform for the dissemination of important findings in basic cardiovascular biology and its translational and clinical applications.